New or recurrent tumor status irrelevant in breast cancer relapse
Both new and recurring cancers will differ significantly from original tumors, and treatment should be tailored to the specific qualities of the second tumor.
Diagnosis & Disease Information
Gene test predicts odds of postchemotherapy survival among women with breast cancer
Among women with newly diagnosed breast cancer, a predictive test successfully identified those with a high probability of survival following taxane and anthracycline chemotherapy.
Gene target expands treatment prospects for liver cancer
The limited therapeutic options for hepatocellular carcinoma may have just broadened with the discovery of a new molecular target for the disease.
Iniparib impressive in triple-negative breast cancer
Adding iniparib to gemcitabine and carboplatin significantly increased clinical benefit and survival—but not toxic effects—in women with metastatic triple-negative breast cancer.
Increased Risk of Recurrence in Subset of Early-Stage HER2-Positive Breast Cancer Patients
Women with early-stage HER2-positve breast cancer are at significant risk of recurrence, according to a study published in the Journal of Clinical Oncology (2009 Nov 2 [Epub ahead of print].
- Loading...
Loading...
Loading... 
Loading...